Stockreport

MiNK Therapeutics, Inc. (NASDAQ:INKT) Q4 2023 Earnings Call Transcript [Yahoo! Finance]

MiNK Therapeutics, Inc.  (INKT) 
PDF Reported EPS is $-0.16 EPS, expectations were $-0.15. INKT isn't one of the 30 most popular stocks among hedge funds at the end of the third quarter ( see the details he [Read more]